Literature DB >> 17664263

Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.

M M Kahl-McDonagh1, A M Arenas-Gamboa, T A Ficht.   

Abstract

Brucellosis is a zoonotic disease with a worldwide distribution that can be transmitted via intentional or accidental aerosol exposure. In order to engineer superior vaccine strains against Brucella species for use in animals as well as in humans, the possibility of challenge infection via aerosol needs to be considered to properly evaluate vaccine efficacy. In this study, we assessed the use of an aerosol chamber to infect deep lung tissue of mice to elicit systemic infections with either Brucella abortus or B. melitensis at various doses. The results reveal that B. abortus causes a chronic infection of lung tissue in BALB/c mice and peripheral organs at low doses. In contrast, B. melitensis infection diminishes more rapidly, and higher infectious doses are required to obtain infection rates in animals similar to those of B. abortus. Whether this difference translates to severity of human infection remains to be elucidated. Despite these differences, unmarked deletion mutants BADeltaasp24 and BMDeltaasp24 consistently confer superior protection to mice against homologous and heterologous aerosol challenge infection and should be considered viable candidates as vaccine strains against brucellosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664263      PMCID: PMC2044518          DOI: 10.1128/IAI.00451-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

Review 1.  Brucella as a biological weapon.

Authors:  G Pappas; P Panagopoulou; L Christou; N Akritidis
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

2.  Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors:  J A Montaraz; A J Winter
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

3.  Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

Authors:  D L Hoover; R M Crawford; L L Van De Verg; M J Izadjoo; A K Bhattacharjee; C M Paranavitana; R L Warren; M P Nikolich; T L Hadfield
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 4.  From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.

Authors:  Jacques Godfroid; Axel Cloeckaert; Jean-Pierre Liautard; Stephan Kohler; David Fretin; Karl Walravens; Bruno Garin-Bastuji; Jean-Jacques Letesson
Journal:  Vet Res       Date:  2005 May-Jun       Impact factor: 3.683

5.  Comparative histopathology in BALB/c mice infected with virulent and attenuated strains of Brucella abortus.

Authors:  F M Enright; L N Araya; P H Elzer; G E Rowe; A J Winter
Journal:  Vet Immunol Immunopathol       Date:  1990-10       Impact factor: 2.046

6.  Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis.

Authors:  Philippe Bossi; Anders Tegnell; Agoritsa Baka; Frank Van Loock; Jan Hendriks; Albrecht Werner; Heinrich Maidhof; Georgios Gouvras
Journal:  Euro Surveill       Date:  2004-12-15

7.  Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models.

Authors:  L L Van De Verg; A B Hartman; A K Bhattacharjee; B D Tall; L Yuan; K Sasala; T L Hadfield; W D Zollinger; D L Hoover; R L Warren
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

8.  T cell subsets in granulomatous inflammation and immunity to L. Monocytogenes and B. abortus.

Authors:  M E Mielke
Journal:  Behring Inst Mitt       Date:  1991-02

9.  Placental pathology of the pregnant mouse inoculated with Brucella abortus strain 2308.

Authors:  L Tobias; D O Cordes; G G Schurig
Journal:  Vet Pathol       Date:  1993-03       Impact factor: 2.221

Review 10.  Laboratory exposures to brucellae and implications for bioterrorism.

Authors:  Pablo Yagupsky; Ellen Jo Baron
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more
  21 in total

1.  The NOD-scid IL2rγnull Mouse Model Is Suitable for the Study of Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Thomas A Ficht; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.

Authors:  A M Arenas-Gamboa; A C Rice-Ficht; M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

Review 3.  Brucellosis: the case for live, attenuated vaccines.

Authors:  Thomas A Ficht; Melissa M Kahl-McDonagh; Angela M Arenas-Gamboa; Allison C Rice-Ficht
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

4.  Systematic annotation and analysis of "virmugens"-virulence factors whose mutants can be used as live attenuated vaccines.

Authors:  Rebecca Racz; Monica Chung; Zuoshuang Xiang; Yongqun He
Journal:  Vaccine       Date:  2012-12-06       Impact factor: 3.641

5.  Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis.

Authors:  Sophie J Smither; Stuart D Perkins; Carwyn Davies; Anthony J Stagg; Michelle Nelson; Helen S Atkins
Journal:  Clin Vaccine Immunol       Date:  2009-03-25

6.  Key role of Toll-like receptor 2 in the inflammatory response and major histocompatibility complex class ii downregulation in Brucella abortus-infected alveolar macrophages.

Authors:  Mariana C Ferrero; M Soledad Hielpos; Natalia B Carvalho; Paula Barrionuevo; Patricia P Corsetti; Guillermo H Giambartolomei; Sergio C Oliveira; Pablo C Baldi
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

Review 7.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

8.  Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.

Authors:  Jianwu Pei; Xicheng Ding; Yaping Fan; Allison Rice-Ficht; Thomas A Ficht
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

Review 9.  Laboratory animal models for brucellosis research.

Authors:  Teane M A Silva; Erica A Costa; Tatiane A Paixão; Renée M Tsolis; Renato L Santos
Journal:  J Biomed Biotechnol       Date:  2011-02-20

10.  Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates.

Authors:  Thomas E Todd; Omar Tibi; Yu Lin; Samantha Sayers; Denise N Bronner; Zuoshuang Xiang; Yongqun He
Journal:  BMC Bioinformatics       Date:  2013-04-17       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.